MCKENZIE KENNINGTON: Open Payments
NPI 1336764323 · SOUTH OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 18 payments from 9 companies in 2025. Trend: 2023 $338 · 2024 $328 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $98 |
| Astellas Pharma US Inc | 4 | $66 |
| Exeltis, USA Inc. | 2 | $33 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Solventum Corporation | 1 | $23 |
| Becton, Dickinson and Company | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| CooperSurgical, Inc. | 1 | $14 |
| Organon LLC | 1 | $11 |
Products named: ZURZUVAE, Veozah, SLYND, BEYFORTUS, PREVENA, BD Onclarity, LILETTA, Paragard T 380A.
Industry payments across UT — which companies pay providers there.
